Literature DB >> 27713391

Resolution of Hepatic Venous Congestion Following Gradual Occlusion of Middle Hepatic Vein Interposition Graft in Living Donor Liver Transplantation.

Varvara A Kirchner1, Shin Hwang1, Gi-Won Song1, Chul-Soo Ahn1, Deok-Bog Moon1, Ki-Hun Kim1, Dong-Hwan Jung1, Tae-Yong Ha1, Gil-Chun Park1, Sung-Gyu Lee1.   

Abstract

BACKGROUND The middle hepatic vein (MHV) interposition vessel graft (IVG) is often occluded within a few months after living-donor liver transplantation (LDLT). We aimed to assess the mechanisms of resolving the hepatic venous congestion (HVC) that develops after gradual occlusion of the MHV-IVG. MATERIAL AND METHODS This study comprised two parts. Part I involved an assessment of the process of HVC resolution in the remnant right liver after donation of an extended left liver graft (n=100). Part II involved an evaluation of the timing and patterns of gradual MHV-IVG occlusion and HVC resolution in LDLT recipients (n=100). RESULTS In Part I, the analysis of 1-week dynamic computed tomography (CT) showed pre-existing collaterals in 8, appropriate compensation in 44, and HVC in 48 patients. In Part II, reconstruction of a segment V vein (V5) and a segment VIII vein (V8) was the most common reconstruction type (n=65). The patency rates of MHV-IVG were 90% at 3 months, 65% at 6 months, 37% at 12 months, and 18% at 24 months. The patency rate of V5 was inferior to that of V8. CT imaging analysis indicated that extrinsic compression of IVG, development of intrahepatic collaterals, and IVG shrinkage were the main mechanisms underlying late MHV-IVG occlusion. Moreover, the timing of MHV-IVG occlusion was well correlated with that of neo-collateralization. CONCLUSIONS MHV-IVG reconstruction effectively prevents HVC in LDLT. Although gradual MHV-IVG occlusion is well compensated by neo-collateralization, we believe that the patency of the IVG should be maintained for at least 6 months after LDLT.

Entities:  

Mesh:

Year:  2016        PMID: 27713391     DOI: 10.12659/aot.900170

Source DB:  PubMed          Journal:  Ann Transplant        ISSN: 1425-9524            Impact factor:   1.530


  6 in total

1.  Clinical sequence of an adult recipient undergone split liver transplantation using a right liver graft with erroneous deprivation of the middle hepatic vein trunk: a case report.

Authors:  Geunhyeok Yang; Shin Hwang; Chul-Soo Ahn; Tae-Yong Ha; Dong-Hwan Jung
Journal:  Korean J Transplant       Date:  2021-07-14

2.  The first years of liver transplantation: experiences at a single center.

Authors:  Phu Hong Pham; Nghia Phuoc Phan; Viet Doan Khac Tran; Viet Quoc Dang; Dat Tien Le; Thuan Duc Nguyen; Long Cong Duy Tran; Bac Hoang Nguyen
Journal:  Korean J Transplant       Date:  2022-06-30

3.  Refined surgical techniques to improve the patency of cryopreserved iliac artery homografts for middle hepatic vein reconstruction during living donor liver transplantation.

Authors:  Gil-Chun Park; Shin Hwang; Dong-Hwan Jung; Tae-Yong Ha; Gi-Won Song; Chul-Soo Ahn; Deok-Bog Moon; Ki-Hun Kim; Young-In Yoon; Hwui-Dong Cho; Jin-Uk Choi; Sung-Gyu Lee
Journal:  Ann Surg Treat Res       Date:  2020-10-28       Impact factor: 1.859

4.  Doppler ultrasound follow-up of middle hepatic vein tributaries-interposition vessel graft in recipients of living donor liver transplantation using modified right lobe grafts.

Authors:  Sunyoung Lee; Kyoung Won Kim; So Yeong Jeong; Kyung Jin Lee; So Yeon Kim; Gi Won Song; Sung Gyu Lee
Journal:  Br J Radiol       Date:  2018-06-14       Impact factor: 3.039

5.  Fibrin glue-infiltrating hemostasis for intractable bleeding from the liver or spleen during liver transplantation.

Authors:  Shin Hwang; Dong-Hwan Jung; Gi-Won Song; Tae-Yong Ha; Eun-Kyeong Jwa; Sung-Gyu Lee
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2016-11-30

6.  Novel use of percutaneous thrombosuction to rescue the early thrombosis of the conduit vein graft after living donor liver transplantation.

Authors:  Kuo-Shyang Jeng; Chun-Chieh Huang; Hao-Yuan Tsai; Jung-Cheng Hsu; Cheng-Kuan Lin; Kuo-Hsin Chen
Journal:  J Vasc Surg Cases Innov Tech       Date:  2018-08-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.